134 related articles for article (PubMed ID: 21659742)
1. A heparin-coated dialysis filter (AN69 ST) does not reduce clotting during hemodialysis when compared to a conventional polysulfone filter (F×8).
Sagedal S; Witczak BJ; Osnes K; Hartmann A; Os I; Eikvar L; Klingenberg O; Brosstad F
Blood Purif; 2011; 32(3):151-5. PubMed ID: 21659742
[TBL] [Abstract][Full Text] [Related]
2. Intermittent saline flushes during haemodialysis do not alleviate coagulation and clot formation in stable patients receiving reduced doses of dalteparin.
Sagedal S; Hartmann A; Osnes K; Bjørnsen S; Torremocha J; Fauchald P; Kofstad J; Brosstad F
Nephrol Dial Transplant; 2006 Feb; 21(2):444-9. PubMed ID: 16234293
[TBL] [Abstract][Full Text] [Related]
3. The clinical evaluation of low-dose heparin in haemodialysis: a prospective study using the heparin-coated AN69 ST membrane.
Chanard J; Lavaud S; Maheut H; Kazes I; Vitry F; Rieu P
Nephrol Dial Transplant; 2008 Jun; 23(6):2003-9. PubMed ID: 18156457
[TBL] [Abstract][Full Text] [Related]
4. The AN69 ST haemodialysis membrane under conditions of two different extracorporeal circuit rinse protocols a comparison of thrombogenicity parameters.
Richtrova P; Opatrny K; Vit L; Sefrna F; Perlik R
Nephrol Dial Transplant; 2007 Oct; 22(10):2978-84. PubMed ID: 17597089
[TBL] [Abstract][Full Text] [Related]
5. Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane.
Lavaud S; Canivet E; Wuillai A; Maheut H; Randoux C; Bonnet JM; Renaux JL; Chanard J
Nephrol Dial Transplant; 2003 Oct; 18(10):2097-104. PubMed ID: 13679486
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of three different methods to prevent dialyzer clotting without causing systemic anticoagulation effect.
Richtrova P; Rulcova K; Mares J; Reischig T
Artif Organs; 2011 Jan; 35(1):83-8. PubMed ID: 20626736
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of coagulation and anti-Xa factor when using a heparin-coated AN69ST® dialyser.
Sánchez-Canel JJ; Pons-Prades R; Salvetti ML; Seores A; Vázquez M; Pérez-Alba A; Tamarit E; Calvo-Gordo C; Villatoro J
Nefrologia; 2012; 32(5):605-12. PubMed ID: 23013946
[TBL] [Abstract][Full Text] [Related]
8. Hemodialysis without heparin: a randomized, controlled, crossover study of two dialysis membranes (AN69ST and polysulfone F60).
Brunet P; Frances J; Vacher-Coponat H; Jaubert D; Lebrun G; Gondouin B; Duval A; Berland Y
Int J Artif Organs; 2011 Dec; 34(12):1165-71. PubMed ID: 22198602
[TBL] [Abstract][Full Text] [Related]
9. A single bolus of a low molecular weight heparin to patients on haemodialysis depletes lipoprotein lipase stores and retards triglyceride clearing.
Näsström B; Stegmayr B; Gupta J; Olivecrona G; Olivecrona T
Nephrol Dial Transplant; 2005 Jun; 20(6):1172-9. PubMed ID: 15797889
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the heparin-binding AN69 ST hemodialysis membrane: II. Clinical studies without heparin administration.
Lavaud S; Paris B; Maheut H; Randoux C; Renaux JL; Rieu P; Chanard J
ASAIO J; 2005; 51(4):348-51. PubMed ID: 16156297
[TBL] [Abstract][Full Text] [Related]
11. Effect of vitamin E coated dialyzers on anticoagulation requirement in hemodialyzed children.
Aoun B; Janssen-Lozinska Y; Ulinski T
Saudi J Kidney Dis Transpl; 2010 May; 21(3):466-70. PubMed ID: 20427870
[TBL] [Abstract][Full Text] [Related]
12. Different effects of enoxaparin and unfractionated heparin on some thrombogenesis markers during hemodialysis: a cross-over study.
Naumnik B; Pawlak K; Myśliwiec M
Thromb Res; 2009 Feb; 123(4):631-6. PubMed ID: 18234290
[TBL] [Abstract][Full Text] [Related]
13. Comparison of two dialysers (AN69ST vs. FX100) for heparin-free dialysis in patients with oral anticoagulation.
Kodras K; Benesch T; Neumann I; Haas M
Blood Purif; 2008; 26(3):226-30. PubMed ID: 18305385
[TBL] [Abstract][Full Text] [Related]
14. Anticoagulation therapy during haemodialysis: a comparative study between two heparin regimens.
Sabry A; Taha M; Nada M; Al Fawzan F; Alsaran K
Blood Coagul Fibrinolysis; 2009 Jan; 20(1):57-62. PubMed ID: 20523166
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo evaluation of enoxaparin removal by continuous renal replacement therapies with acrylonitrile and polysulfone membranes.
Isla A; Gascón AR; Maynar J; Arzuaga A; Corral E; Martín A; Solinís MA; Muñoz JL
Clin Ther; 2005 Sep; 27(9):1444-51. PubMed ID: 16291417
[TBL] [Abstract][Full Text] [Related]
16. Heparin-grafted dialysis membrane allows minimal systemic anticoagulation in regular hemodialysis patients: a prospective proof-of-concept study.
Kessler M; Gangemi C; Gutierrez Martones A; Lacombe JL; Krier-Coudert MJ; Galland R; Kielstein JT; Moureau F; Loughraieb N
Hemodial Int; 2013 Apr; 17(2):282-93. PubMed ID: 22925178
[TBL] [Abstract][Full Text] [Related]
17. Unfractionated heparin but not enoxaparin causes delayed plasma PAI-1 depletion in hemodialysis patients: a prospective study.
Naumnik B; Pawlak K; Mys'liwiec M
Clin Appl Thromb Hemost; 2009 Feb; 15(1):84-91. PubMed ID: 17895513
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulation intensity sufficient for haemodialysis does not prevent activation of coagulation and platelets.
Sagedal S; Hartmann A; Sundstrøm K; Bjørnsen S; Brosstad F
Nephrol Dial Transplant; 2001 May; 16(5):987-93. PubMed ID: 11328905
[TBL] [Abstract][Full Text] [Related]
19. A crossover study of the acrylonitrile-co-methallyl sulfonate and polysulfone membranes for elderly hemodialysis patients: the effect on hemodynamic, nutritional, and inflammatory conditions.
Furuta M; Kuragano T; Kida A; Kitamura R; Nanami M; Otaki Y; Nonoguchi H; Matsumoto A; Nakanishi T
ASAIO J; 2011; 57(4):293-9. PubMed ID: 21499075
[TBL] [Abstract][Full Text] [Related]
20. β-Thromboglobulin may not reflect platelet activation during haemodialysis with the HeprAN membrane.
Sagedal S; Sandvik L; Klingenberg O; Sandset PM
Scand J Clin Lab Invest; 2017 Dec; 77(8):679-684. PubMed ID: 29117741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
